Doctors should think twice about prescribing drugs like Ritalin and Adderall used to treat attention deficit disorder to healthy individuals seeking to boost their brain power, says an article in this weeks edition of the Canadian Medical Association Journal. The authors say prescription stimulants are used by some people for cognitive enhancement in the absence of any medical need.
In my inaugural post about competing to win in the global economy, the enterprise was identified as the engine of wealth creation in market-oriented economies such as Canada, the United States, the European Union, or Japan. When I refer to winning, my metric is simple -- sustainable and profitable sales growth…
It might become even harder now to get into the faculty of law at McGill. The already competitive university is basking in the glory of a new QS World University Rankings that places McGill's law faculty 12th best in the world and No. 1 in Canada.
(Desautels Karl Moore with Devin Bigoness, Project Director at Duke Corporate Education in London): "As many of us prepare to watch The Open Championship (the British Open for those of you in the States), one of the leading contenders will be the US Open Champion Rory McIlroy."
C'est la Faculté de droit de l’Université McGill qui prend la 12ème place du classement mondial QS pour l'année 2011.
In Western medicine, placebos have long been the bridesmaids, never the bride. That’s not surprising: they’re sham pills or simulated medical interventions, seen as handmaidens for use in clinical trials rather than the real thing.
Look up "transhumanism" in Wikipedia and you will find an extensive entry, with enough hyperlinks to keep you occupied for a very long time.
The first step toward becoming one of Grand Challenges Canada's Rising Stars in Global Health was learning to be succinct.
Paul-André Crépeau, mort hier à l'âge de 84 ans, laissera sa marque comme un des plus influents réformateurs du droit québécois.
Anny Fortin, chercheuse à la Faculté de médecine de McGill et native de Baie-Comeau, s'est vu décernée une subvention de 100 000 $ par Grands Défis Canada afin qu'elle puisse poursuivre son projet de recherche visant à traiter une maladie de la peau qui touche des millions de personnes sur la planète.